GenapSys is a company focused on the advancement of universal access to genomic information by delivering an affordable, scalable, and accurate genomic sequencing ecosystem that empowers both academic and clinical research applications.
View all
Cytodyn
Vancouver, United States · Post IPO Equity
Regeneron
Tarrytown, United States · Post IPO Equity
Verve Therapeutics
Cambridge, United States · IPO
Biogen
Cambridge, United States
Pionyr Immunotherapeutics
South San Francisco, United States · Corporate Round
Helix
San Mateo, United States · Series C
Guardant Health
Redwood City, United States · Venture
miR Scientific
New York, United States
Genentech
South San Francisco, United States · Venture
Illumina
San Diego, United States
Scipher Medicine
Waltham, United States · Series D
Natera
Austin, United States · Post IPO Equity